Affymetrix, Ingenuity Ink Co-promotion Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Ingenuity Systems and Affymetrix today announced a deal to co-promote each other's products.

Specifically, the terms of the deal call for the firms to co-promote Ingenuity iReport with Affy's expression microarray products. The combined products, Ingenuity and Affy said, will provide researchers a sample-to-insight continuous workflow "for rapid, confident interpretation of results without the need for bioinformatics experience or support."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.